Trial Examines Tolerance of Maintenance Olaparib in Advanced Ovarian Cancer

Leggi l'articolo originale


An analysis of the phase III SOLO1 trial examined safety signals with olaparib maintenance therapy for women with newly diagnosed advanced ovarian cancer and a BRCA mutation.

Lascia un commento